Be sure to take a good look at the pharmacy’s customer support and medicine service availability on Essenceapotek. You intend to make certain you contact MPs in many ways and that you can communicate all night to get to get assist if anything fails together with your medicine.
Approval cerabone® & maxresorb® in Argentina
Approval maxresorb® in Australia
Approval cerabone®, collprotect® membrane, Jason® membrane, mucoderm®, maxresorb® & maxresorb® inject in India
Approval Jason® membrane, cerabone® & mucoderm® in Philippines
MDSAP (Medical Device Single Audit Program) scope extension to Brazil and Japan as well as recertification for Australia, Canada and United States
botiss participation at 4 ITI congresses
Approval cerabone® in USA
Approval Jason® membrane in USA
Scheduled market launch in USA, Australia, Brazil
MDSAP (Medical Devise Single Audit Program)-certification including ISO 13485:2016
botiss participation at 3 ITI congresses
Fourth bone & tissue days World Congress in Barcelona, Berlin and Warsaw
CE mark approval permamem® and cerabone®
botiss participation at ITI World Symposium in Basel
Third bone & tissue days World Congress in Berlin
Pre-launch of first products in the USA
Straumann takes over exclusive distribution of botiss products in Germany
Market launch of maxgraft® cortico
botiss participation at 8 ITI congresses worldwide
Pharmaceutical approval for maxgraft® and for maxgraft® bonebuilder
Second bone & tissue days World Congress in Berlin with 800 participants
Worldwide cooperation with Straumann in the field of regenerative products
Exclusive cooperation with the Charité tissue bank for the dental regeneration
First bone & tissue days World Congress in Berlin
CE mark approval for mucoderm® and for maxresorb® inject
Acquisition of Cells+Tissubank Austria
CE mark approval for collprotect® membrane
CE mark approcal for Jason® membrane
Establishment of botiss medical AG
CE mark approval for maxresorb®
CE mark approval for cerabone®, employed since 2006 in the dental field